FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066869206> ?p ?o ?g. }

• W2066869206 endingPage "515" @default.
• W2066869206 startingPage "510" @default.
• W2066869206 abstract "Objectives. The combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) is currently considered the most effective chemotherapy for metastatic transitional cell cancer (TCC) of the urinary tract, but because of its considerable toxicity, alternative regimens appear very interesting. We evaluated the efficacy and toxicity of a combination of paclitaxel and carboplatin as first-line therapy for metastatic TCC. Methods. Thirty-two patients (8 women, 24 men; mean age 67.03 years, range 50 to 79) with metastatic TCC of the bladder or upper urinary tract were included in the study. Paclitaxel (175 mg/m2) was given as a 3-hour intravenous infusion, carboplatin was dosed to an area under the plasma concentration curve of 5 mg/mL/min calculated according to the Calvert formula [(creatinine clearance + 25) × 5] as a 30-minute intravenous infusion immediately after paclitaxel. Response evaluation was performed after every 2 cycles and additional therapy depended on response. The maximum number of cycles was 6. Results. With a mean follow-up of 13.1 months (range 2 to 28), 23 of 32 patients responded to treatment (response rate 71.9%), with 31.3% complete remission (CR) (10 of 32) and 40.6% partial remission (PR) (13 of 32). Four patients (12.5%) had stable disease, and 5 patients (15.6%) showed progression. These results compare well with the outcome after MVAC. Toxicity was mainly characterized by neurotoxicity grade 3 and 4 in 9.4%, grade 3 and 4 leukopenia in 37.5%, and grade 3 thrombocytopenia in 3.1% of the patients. No nephrotoxicity was observed, but all patients developed alopecia. Time to progression after CR was a mean of 7.0 months (range 4 to 13) and after PR a mean of 5.9 months (range 2 to 9). Conclusions. Paclitaxel/carboplatin is an effective therapy for metastatic TCC, with low toxicity." @default.
• W2066869206 created "2016-06-24" @default.
• W2066869206 creator A5007900821 @default.
• W2066869206 creator A5034309080 @default.
• W2066869206 creator A5062013810 @default.
• W2066869206 creator A5077948458 @default.
• W2066869206 creator A5077961608 @default.
• W2066869206 creator A5084907442 @default.
• W2066869206 creator A5090482850 @default.
• W2066869206 creator A5090946201 @default.
• W2066869206 date "1999-03-01" @default.
• W2066869206 modified "2023-10-13" @default.
• W2066869206 title "Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tract" @default.
• W2066869206 cites W1514810570 @default.
• W2066869206 cites W1534334787 @default.
• W2066869206 cites W1820014750 @default.
• W2066869206 cites W1840050571 @default.
• W2066869206 cites W1862964936 @default.
• W2066869206 cites W1893740135 @default.
• W2066869206 cites W1939723756 @default.
• W2066869206 cites W1957837469 @default.
• W2066869206 cites W1968487988 @default.
• W2066869206 cites W1980377320 @default.
• W2066869206 cites W1981534406 @default.
• W2066869206 cites W2008702837 @default.
• W2066869206 cites W2014960675 @default.
• W2066869206 cites W2057157978 @default.
• W2066869206 cites W2116996913 @default.
• W2066869206 cites W2119211684 @default.
• W2066869206 cites W2168812605 @default.
• W2066869206 cites W2268861790 @default.
• W2066869206 cites W23441172 @default.
• W2066869206 cites W2397594606 @default.
• W2066869206 cites W2414152456 @default.
• W2066869206 cites W2419086473 @default.
• W2066869206 cites W2439111531 @default.
• W2066869206 cites W4255152173 @default.
• W2066869206 cites W6664079 @default.
• W2066869206 doi "https://doi.org/10.1016/s0090-4295(98)00543-3" @default.
• W2066869206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10096376" @default.
• W2066869206 hasPublicationYear "1999" @default.
• W2066869206 type Work @default.
• W2066869206 sameAs 2066869206 @default.
• W2066869206 citedByCount "38" @default.
• W2066869206 countsByYear W20668692062012 @default.
• W2066869206 crossrefType "journal-article" @default.
• W2066869206 hasAuthorship W2066869206A5007900821 @default.
• W2066869206 hasAuthorship W2066869206A5034309080 @default.
• W2066869206 hasAuthorship W2066869206A5062013810 @default.
• W2066869206 hasAuthorship W2066869206A5077948458 @default.
• W2066869206 hasAuthorship W2066869206A5077961608 @default.
• W2066869206 hasAuthorship W2066869206A5084907442 @default.
• W2066869206 hasAuthorship W2066869206A5090482850 @default.
• W2066869206 hasAuthorship W2066869206A5090946201 @default.
• W2066869206 hasConcept C126322002 @default.
• W2066869206 hasConcept C126894567 @default.
• W2066869206 hasConcept C141071460 @default.
• W2066869206 hasConcept C143998085 @default.
• W2066869206 hasConcept C2776694085 @default.
• W2066869206 hasConcept C2777132456 @default.
• W2066869206 hasConcept C2777292972 @default.
• W2066869206 hasConcept C2778239845 @default.
• W2066869206 hasConcept C2780873365 @default.
• W2066869206 hasConcept C2781451048 @default.
• W2066869206 hasConcept C29730261 @default.
• W2066869206 hasConcept C71924100 @default.
• W2066869206 hasConcept C77411442 @default.
• W2066869206 hasConcept C90924648 @default.
• W2066869206 hasConceptScore W2066869206C126322002 @default.
• W2066869206 hasConceptScore W2066869206C126894567 @default.
• W2066869206 hasConceptScore W2066869206C141071460 @default.
• W2066869206 hasConceptScore W2066869206C143998085 @default.
• W2066869206 hasConceptScore W2066869206C2776694085 @default.
• W2066869206 hasConceptScore W2066869206C2777132456 @default.
• W2066869206 hasConceptScore W2066869206C2777292972 @default.
• W2066869206 hasConceptScore W2066869206C2778239845 @default.
• W2066869206 hasConceptScore W2066869206C2780873365 @default.
• W2066869206 hasConceptScore W2066869206C2781451048 @default.
• W2066869206 hasConceptScore W2066869206C29730261 @default.
• W2066869206 hasConceptScore W2066869206C71924100 @default.
• W2066869206 hasConceptScore W2066869206C77411442 @default.
• W2066869206 hasConceptScore W2066869206C90924648 @default.
• W2066869206 hasIssue "3" @default.
• W2066869206 hasLocation W20668692061 @default.
• W2066869206 hasLocation W20668692062 @default.
• W2066869206 hasOpenAccess W2066869206 @default.
• W2066869206 hasPrimaryLocation W20668692061 @default.
• W2066869206 hasRelatedWork W1502181122 @default.
• W2066869206 hasRelatedWork W2006385338 @default.
• W2066869206 hasRelatedWork W2053778437 @default.
• W2066869206 hasRelatedWork W2100029565 @default.
• W2066869206 hasRelatedWork W2187491254 @default.
• W2066869206 hasRelatedWork W2364024683 @default.
• W2066869206 hasRelatedWork W2380099415 @default.
• W2066869206 hasRelatedWork W2415963934 @default.
• W2066869206 hasRelatedWork W4250038123 @default.
• W2066869206 hasRelatedWork W4310754094 @default.
• W2066869206 hasVolume "53" @default.

• next